Bristol-Myers Squibb Co
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
Hundreds of 1199SEIU health care workers staged a rally and sit to block 3rd avenue where some were arrested. They protested against health care cuts in Governor Kathy Hochuls budget on Medicare. Lev Radin | Lightrocket | Getty Images Medicare on Friday said it will allow pharmaceutical companies to publicly discuss the program’s historic drug […]
Read More
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued the Biden Administration over Medicare’s new powers to slash drug prices for seniors under the Inflation Reduction Act. Pharmaceutical […]
Read More
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit
Bristol Myers Squibb on Friday sued the Biden administration over Medicare’s new powers to slash drug prices, the third such lawsuit to be filed against the program in a matter of days. The lawsuit, filed in federal district court in New Jersey, argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. […]
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there […]
Read More
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO of Merck & Co. Inc., […]
Read More
Stocks making the biggest moves premarket: Meta, Teladoc, Harley-Davidson, Southwest Airlines and more
Harley-Davidson motorcycles are displayed for sale at the Cowboy Harley-Davidson dealership on February 02, 2023 in Austin, Texas. Brandon Bell | Getty Images Check out the companies making headlines before the bell: Meta Platforms – Shares jumped 12% after the Facebook parent surpassed Wall Street’s expectations on the top and bottom lines and issued optimistic […]
Read More
Enjoy protection with these fortress shares in the next quarter
Traders should assume extra volatility as the next quarter gets underway — and they may possibly want to start planning for a recession, experts say. That usually means finding fortress stocks to protect their portfolios. Turmoil in the financial institution sector has renewed fears of an economic slowdown as money institutions tighten lending situations. DoubleLine […]
Read More
Analysts appreciate these stocks that are flush with dollars — giving one more than 75% upside
Investors are planning for a gloomy 2023 by doubling down on funds-abundant companies . “We choose businesses building funds alternatively than those that have to have capital to improve. Not only are costs most likely to stay bigger than they have been in current past, but we are probably exiting an period of hyper-accommodative monetary […]
Read More
Biden administration will select first 10 drugs for Medicare price negotiations by September
The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in a long awaited effort to cut costs for seniors. HHS officials, in a call with reporters on Wednesday, laid out the federal government’s road map […]
Read More